Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infectious Diseases and Therapy
Published in: Infectious Diseases and Therapy 3/2016

Open Access 01-09-2016 | Review

Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review

Authors: Lauren E. Bloomfield, Thomas V. Riley

Published in: Infectious Diseases and Therapy | Issue 3/2016

Login to get access

Abstract

Clostridium difficile infection (CDI) was once considered a primarily nosocomial concern. Emerging evidence from the last 20 years has highlighted a drastic shift in the known epidemiology of CDI, with disease outside of hospitals apparently occurring more frequently and causing severe disease in populations that were thought to be at low risk. This narrative review summarises potential pathways for infection outside of the hospital environment and highlights likely routes of transmission. Further, evidence is presented on potential risk factors for development of disease. Understanding the epidemiology of CDI outside of hospitals is essential to the ability to prevent and control disease in vulnerable populations.
Literature
1.
Barbut F, Petit J-C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect. 2001;7:405–10.PubMedCrossRef
2.
Wilcox MH. Clostridium difficile infection. Hospital Doctor. 2005;1–8. ISSN 02623145.
3.
Williams OM, Spencer RC. The management of Clostridium difficile infection. Br Med Bull. 2009;91(1):87–110.PubMedCrossRef
4.
Henderson DK, Palmore TN. Critical gaps in knowledge of the epidemiology and pathophysiology of healthcare-associated infections. Infect Control Hosp Epidemiol. 2010;31(Suppl 1):S4–6.PubMedCrossRef
5.
Leffler DA, Lamont JT. Not so nosocomial anymore: the growing threat of community-acquired Clostridium difficile. Am J Gastroenterol. 2012;107(1):96–8.PubMedCrossRef
6.
Poxton IR. The changing faces of Clostridium difficile: a personal reflection of the past 34 years. Anaerobe. 2013;24:124–7.PubMedCrossRef
7.
Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994;169(1):127–33 (Epub 1994/01/01. Eng).PubMedCrossRef
8.
Kyne L, Merry C, O’Connell B, Keane C, O’Neill D. Community-acquired Clostridium difficile infection. J Infect. 1998;36:287–8.PubMedCrossRef
9.
Noren T, Akerlund T, Back E, Sjoberg L, Persson I, Alriksson I, et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol. 2004;42(8):3635–43 (Epub 2004/08/07. ).PubMedPubMedCentralCrossRef
10.
11.
Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis. 1995;20(Suppl 2):S263–5 (Epub 1995/06/01).PubMedCrossRef
12.
Riley TV, Wetherall F, Bowman J, Mogyorosy J, Golledge CL. Diarrheal disease due to Clostridium difficile in general practice. Pathology. 1991;23(4):346–9 (Epub 1991/10/01).PubMedCrossRef
13.
Beaugerie L, Flahault A, Barbut F, Atlan P, Lalande V, Cousin P, et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther. 2003;17(7):905–12 (Epub 2003/03/27).PubMedCrossRef
14.
McFarland LV, Beneda HW, Clarridge JE, Raugi GJ. Implications of the changing face of Clostridium difficile disease for health care practitioners. Am J Infect Control. 2007;35(4):237–53 (Epub 2007/05/08).PubMedCrossRef
15.
Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Inf. 2006;12(Suppl 6):2–18.CrossRef
16.
McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Cont Hosp Epidemiol. 2007;28(2):140–5 (Epub 2007/02/01).CrossRef
17.
18.
Jury LA, Sitzlar B, Kundrapu S, Cadnum JL, Summers KM, Muganda CP, et al. Outpatient healthcare settings and transmission of Clostridium difficile. PloS One. 2013;8(7):e70175 (Epub 2013/07/31).PubMedPubMedCentralCrossRef
19.
Viscidi R, Willey S, Bartlett J. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology. 1981;81:5–9.PubMed
20.
Gorbach S. Clostridium difficile settles in a nursing home. Hospital Practice. 1989;24(2):145–60.PubMedCrossRef
21.
Longtin Y, Paquet-Bolduc B, Gilca R, et al. Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of c difficile infections: a quasi-experimental controlled study. JAMA Intern Med. 2016;176(6):796–804. doi:10.​1001/​jamainternmed.​2016.​0177.PubMedCrossRef
22.
Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):1195–205.PubMedCrossRef
23.
Tattevin P, Buffet-Bataillon S, Donnio PY, Revest M, Michelet C. Clostridium difficile infections: do we know the real dimensions of the problem? Int J Antimicrob Agents. 2013;42(Suppl):S36–40 (Epub 2013/05/15).PubMedCrossRef
24.
Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009;15(12):1053–66 (Epub 2009/11/26).PubMedCrossRef
25.
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Cont Hosp Epidemiol. 2010;31(5):431–55 (Epub 2010/03/24).CrossRef
26.
Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7(7):526–36 (Epub 2009/06/17).PubMedCrossRef
27.
Gupta A, Khanna S. Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist. 2014;7:63–72 (Epub 2014/03/29).PubMedPubMedCentral
28.
Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62(2):388–96.PubMedCrossRef
29.
Hensgens MP, Keessen EC, Squire MM, Riley TV, Koene MG, de Boer E, et al. Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect. 2012;18(7):635–45 (Epub 2012/04/28).PubMedCrossRef
30.
Alcala L, Martin A, Marin A, Sanchez-Somolinos M, Catalan P, Pelaez T, et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin Microbiol Infect. 2012;18:E204–13.PubMedCrossRef
31.
Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT, Kuijper E. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect. 2009;15(12):1087–92.PubMedCrossRef
32.
Kyne L, Merry C, O’Connell B, Keane C, O’Neill D. Community-acquired Clostridium difficile infection. J Infect. 1998;36(3):287–8 (Epub 1998/11/20).PubMedCrossRef
33.
Jen MH, Saxena S, Bottle A, Pollok R, Holmes A, Aylin P. Assessment of administrative data for evaluating the shifting acquisition of Clostridium difficile infection in England. J Hosp Infect. 2012;80(3):229–37 (Epub 2012/02/07).PubMedCrossRef
34.
Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet ((London, England)). 2011;377(9759):63–73 (Epub 2010/11/19).CrossRef
35.
Khanna S, Pardi D. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Heptol. 2010;4(4):409–16.CrossRef
36.
Kutty PK, Woods CW, Sena AC, Benoit SR, Naggie S, Frederick J, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010;16(2):197–204 (Epub 2010/02/02).PubMedCrossRef
37.
Lessa FC. Community-associated Clostridium difficile infection: how real is it? Anaerobe. 2013;24:121–3.PubMedCrossRef
38.
Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM. Outcomes in community-acquired Clostridium difficile infection. Aliment Pharmacol Ther. 2012;35(5):613–8.PubMedPubMedCentralCrossRef
39.
Allard R, Dascal A, Camara B, Letourneau J, Valiquette L. Community-acquired Clostridium difficile associated diarrhea, Montreal, 2005–2006: frequency estimates and their validity. Infect Control Hosp Epidemiol. 2011;32(10):1032–4 (Epub 2011/09/21).PubMedCrossRef
40.
Lambert PJ, Dyck M, Thompson LH, Hammond GW. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect Cont Hosp Epidemiol. 2009;30(10):945–51 (Epub 2009/09/08).CrossRef
41.
Tan XQ, Verrall AJ, Jureen R, Riley TV, Collins DA, Lin RT, et al. The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern. Int J Antimicrob Agents. 2014;43(1):47–51.PubMedCrossRef
42.
Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, et al. Increasing incidence of Clostridium difficile infection, Australia, 2011–2012. Med J Aust. 2014;200(5):272–6 (Epub 2014/03/20).PubMedCrossRef
43.
Jamal W, Pauline E, Rotimi V. A prospective study of community-associated Clostridium difficile infection in Kuwait: epidemiology and ribotypes. Anaerobe. 2015;35(Pt B):28–32 (Epub 2015/07/07).
44.
Pituch H. Clostridium difficile is no longer just a nosocomial infection or an infection of adults. Int J Antimicrob Agents. 2009;33:S42–5.PubMedCrossRef
45.
Borriello SP. Pathogenesis of Clostridium difficile infection. J Antimicrob Chemother. 1998;41(Suppl C):13–9 (Epub 1998/06/18).
46.
47.
Juneau C, Mendias EN, Wagal N, Loeffelholz M, Savidge T, Croisant S, et al. Community-acquired infection: awareness and clinical implications. JNP. 2013;9(1):1–6.PubMedPubMedCentral
48.
Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis. 2011;11:194.PubMedPubMedCentralCrossRef
49.
Kuijper EJ, van Dissel JT. Spectrum of Clostridium difficile infections outside health care facilities. CMAJ = journal de l’Association medicale canadienne. 2008;179(8):747–8 (Epub 2008/10/08).
50.
Khanna S, Baddour LM, Huskins WC, Kammer PP, Faubion WA, Zinsmeister AR, et al. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis. 2013;56(10):1401–6 (Epub 2013/02/15).PubMedPubMedCentralCrossRef
51.
Naggie S, Frederick J, Pien BC, Miller BA, Provenzale DT, Goldberg KC, et al. Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. Infection. 2010;38(4):297–300 (Epub 2010/05/11).PubMedCrossRef
52.
Delaney JA, Dial S, Barkun A, Suissa S. Antimicrobial drugs and community-acquired Clostridium difficile-associated disease. UK. Emerg Infect Dis. 2007;13(5):761–3 (Epub 2007/06/08).PubMedCrossRef
53.
Holzbauer SM, Kemperman MM, Lynfield R. Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected lyme disease. Clin Infect Dis. 2010;51(3):369–70 (Epub 2010/07/06).PubMedCrossRef
54.
Kandel C, Moayedi Y, Bunce PE. A woman with community-acquired Clostridium difficile infection. CMAJ = journal de l’Association medicale canadienne. 2012;184(12):1383–5 (Epub 2012/07/25).
55.
Heslop OD, Roye-Green K, Coard K, Mulvey MR. A unique strain of community-acquired Clostridium difficile in severe complicated infection and death of a young adult. BMC Infect Dis. 2013;13:299–302.PubMedPubMedCentralCrossRef
56.
Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Sferra TJ, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother. 2013;68(9):1951–61.PubMedCrossRef
57.
Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881–91. doi:10.​1093/​jac/​dkt477 (Epub 2013/12/08).PubMedCrossRef
58.
Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62(2):388–96.PubMedCrossRef
59.
Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile–Connecticut, 2006. MMWR Morbidity and mortality weekly report. 2008;57(13):340–343 (Epub 2008/04/04).
60.
Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013;173(14):1359–67.PubMedCrossRef
61.
McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis. 2007;45(9):1141–51 (Epub 2007/10/06).
62.
Dial S, Delaney J, Barkan A, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile–associated disease. J Am Med Assoc. 2005;294(23):2989–95.CrossRef
63.
Esposito A, Agraharkar M, Pitts W. Community-acquired, antibiotic-unassociated, Clostridium difficile colitis: report of four patients. Infect Dis Clin Pract. 1997;6(6):385–90.CrossRef
64.
Collins CE, Ayturk MD, Flahive JM, Emhoff TA, Anderson FA, Jr., Santry HP. Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries. J Am Coll Surg. 2014;218(6):1141–7 e1 (Epub 2014/04/24).
65.
Dial S, Delaney JAC, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile–associated disease. J Am Med Assoc. 2005;293(23):2989–95.CrossRef
66.
Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ = journal de l’Association medicale canadienne. 2006;175(7):745–8 (Epub 2006/09/27).
67.
68.
Naggie S, Miller BA, Zuzak KB, Pence BW, Mayo AJ, Nicholson BP, et al. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med. 2011;124(3):276 e1–7 (Epub 2011/03/15).
69.
Clooney AG, Bernstein CN, Leslie WD, Vagianos K, Sargent M, Laserna-Mendieta EJ, et al. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors. Aliment Pharmacol Ther. 2016;43(9):974–84 (Epub 2016/03/01).PubMedCrossRef
70.
Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740–8 (Epub 2015/12/15).PubMedCrossRef
71.
Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2014;2:42 (Epub 2014/11/27. eng).PubMedPubMedCentralCrossRef
72.
Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum. 2009;52(1):40–5 (Epub 2009/03/11).PubMedCrossRef
73.
Cojocariu C, Stanciu C, Stoica O, Singeap AM, Sfarti C, Girleanu I, et al. Clostridium difficile infection and inflammatory bowel disease. Turk J Gastroenterol. 2014;25(6):603–10 (Epub 2015/01/21).PubMedCrossRef
74.
Stoica O, Trifan A, Cojocariu C, Girleanu I, Maxim R, Stanciu MC. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2015;119(1):81–6 (Epub 2015/05/15).PubMed
75.
Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8(4):244–50 (Epub 2002/07/20).PubMedCrossRef
76.
Goodhand JR, Alazawi W, Rampton DS. Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33(4):428–41.PubMedCrossRef
77.
Patriarchi F, Rolla M, Maccioni F, Menichella A, Scacchi C, Ambrosini A, et al. Clostridium difficile-related pancolitis in lung-transplanted patients with cystic fibrosis. Clin Transplant. 2011;25(1):E46–51 (Epub 2010/07/21).
78.
Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002;23(11):653–9.PubMedCrossRef
79.
Hall I, O’Toole E. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child. 1935;49:390–402.CrossRef
80.
Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, Collignon A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis. 2012;55(9):1209–15.PubMedCrossRef
81.
Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Clostridium difficile in children: colonisation and disease. J Infect. 2011;63(2):105–13 (Epub 2011/06/15).
82.
Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatric Gastroenterol Nutr. 2010;51(1):2–7 (Epub 2010/06/01).
83.
Soes LM, Holt HM, Bottiger B, Nielsen HV, Andreasen V, Kemp M, et al. Risk factors for Clostridium difficile infection in the community: a case-control study in patients in general practice, Denmark, 2009–2011. Epidemiol Infect. 2014;142(7):1437–48 (Epub 2013/10/01).PubMedCrossRef
84.
Toltzis P, Zaoutis T. Community-associated Clostridium difficile infection in children. Clin Infect Dis. 2013;57(12):1673–5 (Epub 2013/09/21).PubMedCrossRef
85.
Fellmeth G, Yarlagadda S, Iyer S. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England. J Infect Pub Health. 2010;3(3):118–23 (Epub 2010/09/28).CrossRef
86.
Gutierrez RL, Riddle MS, Porter CK. Epidemiology of Clostridium difficile infection among active duty United States military personnel (1998–2010). BMC Infect Dis. 2013;13:609 (Epub 2014/01/01).
87.
Chernak E, Weltman A, McDonald L, Wiggs L, Killgore G, Thompson A, et al. Severe Clostridium difficile-associated disease in populations previously at low risk–four states, 2005. MMWR. 2005;54(47):1201–5 (Epub 2005/12/02).
88.
Rouphael NG, O’Donnell JA, Bhatnagar J, Lewis F, Polgreen PM, Beekmann S, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol. 2008;198(6):635 e1–6 (Epub 2008/04/09).
89.
Denno DM, Shaikh N, Stapp JR, Qin X, Hutter CM, Hoffman V, et al. Diarrhea etiology in a pediatric emergency department: a case control study. Clin Infect Dis. 2012;55(7):897–904 (Epub 2012/06/16).PubMedPubMedCentralCrossRef
90.
Otten AM, Reid-Smith RJ, Fazil A, Weese JS. Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect. 2010;138(6):907–14.PubMedCrossRef
91.
Alam MJ, Anu A, Walk ST, Garey KW. Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe. 2014;27:31–3 (Epub 2014/03/25).PubMedCrossRef
92.
Weese JS, Finley R, Reid-Smith RR, Janecko N, Rousseau J. Evaluation of Clostridium difficile in dogs and the household environment. Epidemiol Infect. 2010;138(8):1100–4.PubMedCrossRef
93.
Al Saif N, Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol. 1996;45(2):133–7.
94.
Simango C. Prevalence of Clostridium difficile in the environment in a rural community in Zimbabwe. Trans R Soc Trop Med Hyg. 2006;100:1146–50.PubMedCrossRef
95.
Levett PN. Clostridium difficile in habitats other than the human gastro-intestinal tract. J Infect. 1986;12(3):253–63 (Epub 1986/05/01. eng).
96.
Zidaric V, Beigot S, Lapajne S, Rupnik M. The occurrence and high diversity of Clostridium difficile genotypes in rivers. Anaerobe. 2010;16(4):371–5 (Epub 2010/06/15).PubMedCrossRef
97.
Nikaeen M, Aghili Dehnavi H, Hssanzadeh A, Jalali M. Occurrence of Clostridium difficile in two types of wastewater treatment plants. J Formos Med Assoc = Taiwan yi zhi. 2015;114(7):663–5 (Epub 2015/05/10).
98.
Romano V, Pasquale V, Krovacek K, Mauri F, Demarta A, Dumontet S. Toxigenic Clostridium difficile PCR ribotypes from wastewater treatment plants in southern Switzerland. Appl Environ Microbiol. 2012;78(18):6643–6.PubMedPubMedCentralCrossRef
99.
Viau E, Peccia J. Survey of wastewater indicators and human pathogen genomes in biosolids produced by class A and class B stabilization treatments. Appl Environ Microbiol. 2009;75(1):164–74 (Epub 2008/11/11).PubMedCrossRef
100.
Hensgens M, Keessen EC, Squire M, Riley TV, Koene M, de Boer E, et al. Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect. 2012;18(7):635–45.PubMedCrossRef
101.
Songer JG. Clostridia as agents of zoonotic disease. Vet Microbiol. 2010;140(3–4):399–404 (Epub 2009/08/18).PubMedCrossRef
102.
Arroyo LG, Kruth SA, Willey BM, Staempfli HR, Low DE, Weese JS. PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol. 2005;54(Pt 2):163–6 (Epub 2005/01/28).
103.
Keel K, Brazier JS, Post KW, Weese S, Songer JG. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol. 2007;45(6):1963–4 (Epub 2007/04/13).PubMedPubMedCentralCrossRef
104.
Rupnik M, Widmer A, Zimmermann O, Eckert C, Barbut F. Clostridium difficile toxinotype V, ribotype 078, in animals and humans. J Clin Microbiol. 2008;46(6):2146 (Epub 2008/04/18).PubMedPubMedCentralCrossRef
105.
Pirs T, Ocepek M, Rupnik M. Isolation of Clostridium difficile from food animals in Slovenia. J Med Microbiol. 2008;57(Pt 6):790–2 (Epub 2008/05/16).
106.
Debast SB, van Leengoed LA, Goorhuis A, Harmanus C, Kuijper EJ, Bergwerff AA. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol. 2009;11(2):505–11 (Epub 2009/02/07).PubMedCrossRef
107.
Avbersek J, Janezic S, Pate M, Rupnik M, Zidaric V, Logar K, et al. Diversity of Clostridium difficile in pigs and other animals in Slovenia. Anaerobe. 2009;15(6):252–5 (Epub 2009/07/28).PubMedCrossRef
108.
George WL, Rolfe RD, Sutter VL, Finegold SM. Diarrhea and colitis associated with antimicrobial therapy in man and animals. Am J Clin Nutr. 1979;32(1):251–7 (Epub 1979/01/01).PubMed
109.
Weese JS, Armstrong J. Outbreak of Clostridium difficile-associated disease in a small animal veterinary teaching hospital. J Vet Intern Med/Am Coll Vet Intern Med. 2003;17(6):813–6 (Epub 2003/12/09).
110.
Songer JG, Post KW, Larson DVM, Jost H, Glock R. Infection of neonatal swine with Clostridium difficile. Swine Health Prod. 2000;8(4):185–9.
111.
Kiss D, Bilkei G. A new periparturient disease in Eastern Europe, Clostridium difficile causes postparturient sow losses. Theriogenology. 2005;63(1):17–23 (Epub 2004/12/14).PubMedCrossRef
112.
Yaeger M, Funk N, Hoffman L. A survey of agents associated with neonatal diarrhea in Iowa swine including Clostridium difficile and porcine reproductive and respiratory syndrome virus. J Vet Diagn Investig. 2002;14(4):281–7 (Epub 2002/08/03).CrossRef
113.
Rodriguez-Palacios A, Borgmann S, Kline TR, LeJeune JT. Clostridium difficile in foods and animals: history and measures to reduce exposure. Anim Health Res Rev/Conf Res Work Anim Dis. 2013;14(1):11–29.CrossRef
114.
115.
Weese JS. Clostridium difficile in food—innocent bystander or serious threat? Clin Microbiol Infect. 2010;16(1):3–10.PubMedCrossRef
116.
Norman KN, Harvey RB, Scott HM, Hume ME, Andrews K, Brawley AD. Varied prevalence of Clostridium difficile in an integrated swine operation. Anaerobe. 2009;15(6):256–60 (Epub 2009/09/26).PubMedCrossRef
117.
Weese JS, Wakeford T, Reid-Smith R, Rousseau J, Friendship R. Longitudinal investigation of Clostridium difficile shedding in piglets. Anaerobe. 2010;16(5):501–4 (Epub 2010/08/17).
118.
Weese JS. Clostridium difficile in food–innocent bystander or serious threat? Clin Microbiol Infect. 2010;16(1):3–10 (Epub 2009/12/17).PubMedCrossRef
119.
Keessen EC, Gaastra W, Lipman LJ. Clostridium difficile infection in humans and animals, differences and similarities. Vet Microbiol. 2011;153(3–4):205–17.PubMedCrossRef
120.
Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci. 2005;84(4):634–43 (Epub 2005/04/23).PubMedCrossRef
121.
Wegener HC. Antibiotics in animal feed and their role in resistance development. Curr Opin Microbiol. 2003;6(5):439–45 (Epub 2003/10/24).PubMedCrossRef
122.
Songer JG. The emergence of Clostridium difficile as a pathogen of food animals. Anim Health Res Rev/Conf Res Work Anim Dis. 2004;5(2):321–6 (Epub 2005/06/30).CrossRef
123.
Nagy J, Bilkei G. Neonatal piglet losses associated with Escherichia coli and Clostridium difficile infection in a Slovakian outdoor production unit. Vet J (London, England: 1997). 2003;166(1):98–100 (Epub 2003/06/06).
124.
Hopman NE, Keessen EC, Harmanus C, Sanders IM, van Leengoed LA, Kuijper EJ, et al. Acquisition of Clostridium difficile by piglets. Vet Microbiol. 2011;149(1–2):186–92 (Epub 2010/11/30).PubMedCrossRef
125.
Keessen EC, Donswijk CJ, Hol SP, Hermanus C, Kuijper EJ, Lipman LJ. Aerial dissemination of Clostridium difficile on a pig farm and its environment. Environ Res. 2011;111(8):1027–32 (Epub 2011/10/22).PubMedCrossRef
126.
Rodriguez C, Avesani V, Van Broeck J, Taminiau B, Delmee M, Daube G. Presence of Clostridium difficile in pigs and cattle intestinal contents and carcass contamination at the slaughterhouse in Belgium. Int J Food Microbiol. 2013;166(2):256–62 (Epub 2013/08/27).PubMedCrossRef
127.
Medina-Torres CE, Weese JS, Staempfli HR. Prevalence of Clostridium difficile in horses. Vet Microbiol. 2011;152(1–2):212–5 (Epub 2011/05/17).PubMedCrossRef
128.
Rodriguez C, Taminiau B, Van Broeck J, Avesani V, Delmee M, Daube G. Clostridium difficile in young farm animals and slaughter animals in Belgium. Anaerobe. 2012;18(6):621–5 (Epub 2012/10/09).PubMedCrossRef
129.
Keessen EC, Harmanus C, Dohmen W, Kuijper EJ, Lipman LJ. Clostridium difficile infection associated with pig farms. Emerg Infect Dis. 2013;19(6):1032–4 (Epub 2013/06/06).PubMedPubMedCentralCrossRef
130.
Clooten J, Kruth S, Arroyo L, Weese JS. Prevalence and risk factors for Clostridium difficile colonization in dogs and cats hospitalized in an intensive care unit. Vet Microbiol. 2008;129(1–2):209–14 (Epub 2008/01/01).
131.
Schneeberg A, Rupnik M, Neubauer H, Seyboldt C. Prevalence and distribution of Clostridium difficile PCR ribotypes in cats and dogs from animal shelters in Thuringia, Germany. Anaerobe. 2012;18(5):484–8 (Epub 2012/09/07).
132.
Wetterwik KJ, Trowald-Wigh G, Fernstrom LL, Krovacek K. Clostridium difficile in faeces from healthy dogs and dogs with diarrhea. Acta Vet Scand. 2013;55:23 (Epub 2013/03/19).
133.
Bandelj P, Trilar T, Blagus R, Ocepek M, Rousseau J, Weese JS, et al. Prevalence and molecular characterization of Clostridium difficile isolated from European Barn Swallows (Hirundo rustica) during migration. BMC Vet Res. 2014;10:40 (Epub 2014/02/11).
134.
Silva RO, D’Elia ML, Tostes Teixeira EP, Pereira PL, de Magalhaes Soares DF, Cavalcanti AR, et al. Clostridium difficile and Clostridium perfringens from wild carnivore species in Brazil. Anaerobe. 2014;28:207–11 (Epub 2014/07/01).PubMedCrossRef
135.
Rodriguez-Palacios A, Staempfli HR, Duffield T, Weese JS. Clostridium difficile in retail ground meat. Canada. Emerg Infect Dis. 2007;13(3):485–7.PubMedCrossRef
136.
Limbago B, Thompson AD, Greene SA, MacCannell D, MacGowan CE, Jolbitado B, et al. Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats. Food Microbiol. 2012;32(2):448–51 (Epub 2012/09/19).
137.
Visser M, Sephri S, Olson N, Du T, Mulvey MR, Alfa MJ. Detection of Clostridium difficile in retail ground meat products in Manitoba. Can J Infect Dis Med Microbiol = Journal canadien des maladies infectieuses et de la microbiologie medicale/AMMI Canada. 2012 Spring;23(1):28–30 (Epub 2013/03/02).
138.
139.
de Boer E, Zwartkruis-Nahuis A, Heuvelink AE, Harmanus C, Kuijper EJ. Prevalence of Clostridium difficile in retailed meat in the Netherlands. Int J Food Microbiol. 2011;144(3):561–4.PubMedCrossRef
140.
Killgore GE, Limbago BM, McDonald LC, Songer JG, Thompson AD, Trinh HT. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15:819+. (English).
141.
Metcalf D, Reid-Smith RJ, Avery BP, Weese JS. Prevalence of Clostridium difficile in retail pork. Can Vet J. 2010;51(8):873–6.PubMedPubMedCentral
142.
Weese JS, Reid-Smith RJ, Avery BP, Rousseau J. Detection and characterization of Clostridium difficile in retail chicken. Lett Appl Microbiol. 2010;50(4):362–5.PubMedCrossRef
143.
Jobstl M, Heuberger S, Indra A, Nepf R, Kofer J, Wagner M. Clostridium difficile in raw products of animal origin. Int J Food Microbiol. 2010;138(1–2):172–5.PubMedCrossRef
144.
Quesada-Gomez C, Mulvey MR, Vargas P, Gamboa-Coronado Mdel M, Rodriguez C, Rodriguez-Cavillini E. Isolation of a toxigenic and clinical genotype of Clostridium difficile in retail meats in Costa Rica. J Food Protect. 2013;76(2):348–51 (Epub 2013/02/26).CrossRef
145.
Deng K, Plaza-Garrido A, Torres JA, Paredes-Sabja D. Survival of Clostridium difficile spores at low temperatures. Food Microbiol. 2015;46:218–21 (Epub 2014/12/06).
146.
Rodriguez-Palacios A, Reid-Smith RJ, Staempfli HR, Weese JS. Clostridium difficile survives minimal temperature recommended for cooking ground meats. Anaerobe. 2010;16(5):540–2 (Epub 2010/05/22).PubMedCrossRef
147.
148.
Pepin J, Gonzales M, Valiquette L. Risk of secondary cases of Clostridium difficile infection among household contacts of index cases. J Infect. 2012;64(4):387–90.PubMedCrossRef
149.
Kim KH, Fekety R, Batts DH, Brown D, Cudmore M, Silva J Jr, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):42–50 (Epub 1981/01/01. eng).PubMedCrossRef
150.
Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529–49.PubMedPubMedCentralCrossRef
151.
Dawson LF, Valiente E, Wren BW. Clostridium difficile—a continually evolving and problematic pathogen. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2009;9(6):1410–7.CrossRef
152.
Ogielska M, Lanotte P, Le Brun C, Valentin AS, Garot D, Tellier AC, et al. Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature. Int J Infect Dis. 2015;37:36–41 (Epub 2015/06/21).PubMedCrossRef
153.
McMullen KM, Mayfield JL, Abdul-Hakim A, Warren DK, Dubberke ER. Assessing colectomies due to Clostridium difficile infection: increases in the community, but not in the referral center. Am J Infect Control. 2012;40(8):778–80 (Epub 2012/01/31).PubMedCrossRef
Metadata
Title
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review
Authors
Lauren E. Bloomfield
Thomas V. Riley
Publication date
01-09-2016
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue 3/2016
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-016-0117-y

Other articles of this Issue 3/2016

Infectious Diseases and Therapy 3/2016 Go to the issue

Review

New Antiretroviral Treatment for HIV

Review

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Original Research

Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

Erratum

Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

Review

Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need

Original Research

Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits